Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis
PolandStudy of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)
FranceStudy on Risankizumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Isatuximab for Patients with Type I Cryoglobulinemia
FranceStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
BelgiumStudy to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed
FranceStudy on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients
The NetherlandsStudy on the Effects of Abiprubart for Patients with Sjögren’s Disease
CzechiaStudy on the Effectiveness and Safety of Cyclosporine and Methotrexate for Children and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness of Doravirine and Dolutegravir for People with HIV Switching Antiretroviral Therapy
ItalyStudy on the Safety and Effectiveness of tolDC for Patients with Relapsing Remitting and Progressive Multiple Sclerosis
BelgiumStudy on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients
ItalyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
